| Catholic Community Hospice 425 West 85th Street, Kansas City, MO, 64114 | |
| (816) 523-5634 |
News Archive
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.
› Verified 1 days ago
| Name | Catholic Community Hospice |
|---|---|
| Location | 425 West 85th Street, Kansas City, Missouri |
| Hospice ID | 261644 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Church |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
| SSA county code | 470 |
News Archive
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.
› Verified 1 days ago
| NPI Number | 1275542862 |
| Organization Name | Catholic Charities Of Northeast Kansas Inc |
| Address | 425 W 85th St Kansas City, Missouri, 64114 |
| Phone Number | (816)523-5634 |
News Archive
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 93.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 93.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.
› Verified 1 days ago
| Home Health Aides | 0.5 |
| Counselors | 0.5 |
| Licensed Practical or Vocational Nurses | 0.25 |
| Medical Social Workers | 0.25 |
| Registered Nurses | 0.5 |
| Total Employees | 2 |
|---|
News Archive
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.
› Verified 1 days ago
| Others | 0.1 |
| Total Volunteers | 0.1 |
|---|
News Archive
A new drive to harness the research potential of the NHS was given a further boost today by the creation of the UK Clinical Research Collaboration (UKCRC).
In a letter to theFood and Drug Administration (FDA), the American Medical Association (AMA) today called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist. The letter was sent to the Molecular and Clinical Genetics Panel of the FDA's Medical Devices Advisory Committee regarding direct to consumer genetic tests prior to the panel's hearings on the topic, scheduled for March 8 and 9.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.
Young women with early-stage breast cancer have similar survival rates with a lumpectomy and radiation treatment, known as breast-conservation therapy, as with mastectomy, a new study conducted at the University of Maryland has found. The results of the analysis of nearly 15,000 patients listed in a nationwide cancer registry will be presented at the 2011 Breast Cancer Symposium to be held Sept. 8-11 in San Francisco.
› Verified 1 days ago
| Kansas City Hospice And Palliative Care Location: 1500 Meadow Lake Parkway, Suite 200, Kansas City, Missouri, 64114 Phone: (816) 523-5634 |
| Slh Home Care And Hospice Location: 3100 Broadway, Suite 1000, Kansas City, Missouri, 64111 Phone: (816) 523-5634 |
| Hospice Partners Location: 8301 State Line Rd, Suite 103, Kansas City, Missouri, 64114 Phone: (816) 523-5634 |
| Aseracare Hospice Location: 8357 Nw Barrybrooke Drive, Kansas City, Missouri, 64151 Phone: (816) 523-5634 |